Patients affected by chronic kidney disease (CKD) exhibit a high risk of cardiovascular mortality that is poorly explained by traditional risk factors. There is a growing awareness about the role of derangement of mineral metabolism that is currently accepted as a trigger and sustainer of cardiovascular disease (CVD) in CKD patients. The synthetic definition of CKD mineral and bone disorder (CKD-MBD) split the concept that the indexes of mineral metabolism extend their effects beyond the bone until the vascular wall and metabolic milieu of CKD patients through complex pathways. A better understanding of the biomarkers and mechanisms of left ventricular hypertrophy, CVD, inflammation, and chronic renal damage may help with the diagnosis and treatment of the systemic impairment that occurs secondary to CKD-MBD, thus slowing the progression of renal and CVD and improving patient survival. Recent insights into fibroblast growth factor (FGF) 23 have led to marked advancement in interpreting data on CVD and CKD progression ascribing to FGF23 a pivotal role in these pathologies independent of its co-receptor klotho and well beyond mineral metabolism. This review article will discuss the current experimental and clinical evidence regarding the role of FGF23 in physiology and pathophysiology of CKD and its associated complications with an emphasis on CVD.

Fibroblast Growth Factor 23: Mineral Metabolism and Beyond / Grabner, Alexander; Mazzaferro, Sandro; Cianciolo, Giuseppe; Krick, Stefanie; Capelli, Irene; Rotondi, Silverio; Ronco, Claudio; La Manna, Gaetano; Faul, Christian. - In: CONTRIBUTIONS TO NEPHROLOGY. - ISSN 0302-5144. - STAMPA. - 190:(2017), pp. 83-95. [10.1159/000468952]

Fibroblast Growth Factor 23: Mineral Metabolism and Beyond

MAZZAFERRO, SANDRO;ROTONDI, SILVERIO;
2017

Abstract

Patients affected by chronic kidney disease (CKD) exhibit a high risk of cardiovascular mortality that is poorly explained by traditional risk factors. There is a growing awareness about the role of derangement of mineral metabolism that is currently accepted as a trigger and sustainer of cardiovascular disease (CVD) in CKD patients. The synthetic definition of CKD mineral and bone disorder (CKD-MBD) split the concept that the indexes of mineral metabolism extend their effects beyond the bone until the vascular wall and metabolic milieu of CKD patients through complex pathways. A better understanding of the biomarkers and mechanisms of left ventricular hypertrophy, CVD, inflammation, and chronic renal damage may help with the diagnosis and treatment of the systemic impairment that occurs secondary to CKD-MBD, thus slowing the progression of renal and CVD and improving patient survival. Recent insights into fibroblast growth factor (FGF) 23 have led to marked advancement in interpreting data on CVD and CKD progression ascribing to FGF23 a pivotal role in these pathologies independent of its co-receptor klotho and well beyond mineral metabolism. This review article will discuss the current experimental and clinical evidence regarding the role of FGF23 in physiology and pathophysiology of CKD and its associated complications with an emphasis on CVD.
2017
FGF23, Chronic renal failure, Cardiovascular disease
01 Pubblicazione su rivista::01g Articolo di rassegna (Review)
Fibroblast Growth Factor 23: Mineral Metabolism and Beyond / Grabner, Alexander; Mazzaferro, Sandro; Cianciolo, Giuseppe; Krick, Stefanie; Capelli, Irene; Rotondi, Silverio; Ronco, Claudio; La Manna, Gaetano; Faul, Christian. - In: CONTRIBUTIONS TO NEPHROLOGY. - ISSN 0302-5144. - STAMPA. - 190:(2017), pp. 83-95. [10.1159/000468952]
File allegati a questo prodotto
File Dimensione Formato  
Grabner_growth-factor_2017.pdf

solo gestori archivio

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 196.05 kB
Formato Adobe PDF
196.05 kB Adobe PDF   Contatta l'autore

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/971064
Citazioni
  • ???jsp.display-item.citation.pmc??? 14
  • Scopus 33
  • ???jsp.display-item.citation.isi??? 26
social impact